Company Information

CIN
Status
Date of Incorporation
10 August 1946
State / ROC
Mumbai / ROC Mumbai
Last Balance Sheet
31 March 2023
Last Annual Meeting
23 September 2023
Paid Up Capital
8,612,400
Authorised Capital
9,000,000

Directors

Anuradha Aurora
Anuradha Aurora
Director/Designated Partner
over 2 years ago
Satyanarayan Agarwal
Satyanarayan Agarwal
Director/Designated Partner
almost 3 years ago
Jagadish Chinnappa
Jagadish Chinnappa
Director/Designated Partner
almost 3 years ago
Neha Aurora
Neha Aurora
Beneficial Owner
over 6 years ago
Krishnamurthy Venkataramani
Krishnamurthy Venkataramani
Director/Designated Partner
over 17 years ago
Noshir Burjor Shroff
Noshir Burjor Shroff
Nodal Officer
over 17 years ago

Past Directors

Yogesh Saran Aurora
Yogesh Saran Aurora
Additional Director
over 5 years ago
Suneet Aurora
Suneet Aurora
Whole Time Director
over 16 years ago
Kashmiri Lal Kapoor
Kashmiri Lal Kapoor
Additional Director
over 17 years ago
Krishan Kumar Aurora
Krishan Kumar Aurora
Additional Director
over 17 years ago

Registered Trademarks

Magnepro Pharmed

[Class : 5] Pharmaceuticals, Medical And Veterinary Preparations; Sanitary Preparations For Medical Purposes; Dietetic Food And Substances Adapted For Medical Or Veterinary Use, Food For Babies; Dietary Supplements For Humans And Animals.

Triactin Mr Pharmed

[Class : 5] Pharmaceuticals, Medical And Veterinary Preparations; Sanitary Preparations For Medical Purposes; Dietetic Food And Substances Adapted For Medical Or Veterinary Use, Food For Babies; Dietary Supplements For Humans And Animals.

Triactin Pharmed

[Class : 5] Pharmaceuticals, Medical And Veterinary Preparations; Sanitary Preparations For Medical Purposes; Dietetic Food And Substances Adapted For Medical Or Veterinary Use, Food For Babies; Dietary Supplements For Humans And Animals.
View +160 more Brands for Pharmed Limited.

Documents

Form Addendum to AOC-4 CSR-29032024_signed
Form MGT-7-15112023_signed
Optional Attachment-(1)-10112023
List of share holders, debenture holders;-10112023
Optional Attachment-(2)-10112023
Copy of MGT-8-10112023
Form AOC-4(XBRL)-19102023-signed
Optional Attachment-(1)-27092023
XBRL document in respect Consolidated financial statement-27092023
Optional Attachment-(2)-27092023
XBRL financial statements duly authenticated as per section 134 (including Board's report,auditor's report and other documents)-27092023
Form Addendum to AOC-4 CSR-01092023_signed
Form Addendum to AOC-4 CSR-30032023
Form PAS-6-29112022
Optional Attachment-(1)-29112022
Form MSME FORM I-26102022_signed
Form MGT-14-04102022_signed
Form AOC-4(XBRL)-04102022_signed
Optional Attachment-(1)-03102022
List of share holders, debenture holders;-03102022
Optional Attachment-(2)-03102022
Copy of MGT-8-03102022
Form MGT-7-03102022_signed
XBRL financial statements duly authenticated as per section 134 (including Board's report,auditor's report and other documents)-01102022
XBRL document in respect Consolidated financial statement-01102022
Optional Attachment-(2)-01102022
Optional Attachment-(1)-01102022
Copy(s) of resolution(s) along with copy of explanatory statement under section 173-28092022
Form AOC-5-25082022-signed
Copy of board resolution-22082022